|
🐬
|
Modeling patients’ time, travel, and monitoring costs in anticoagulation management: societal savings achievable with the shift from warfarin to direct oral anticoagulants
A. Leminen,
Mikko Pyykönen,
Juho Tynkkynen,
M. Tykkyläinen,
T. Laatikainen
|
4 |
2019 |
4
🐬
|
|
🦁
|
Patient-specific and healthcare real-world costs of atrial fibrillation in individuals treated with direct oral anticoagulant agents or warfarin
Mikko Pyykönen,
M. Linna,
M. Tykkyläinen,
E. Delmelle,
T. Laatikainen
|
3 |
2021 |
3
🦁
|
|
🦁
|
A geospatial model to determine the spatial cost-efficiency of anticoagulation drug therapy: Patients' perspective.
Mikko Pyykönen,
A. Leminen,
Juho Tynkkynen,
M. Tykkyläinen,
T. Laatikainen
|
1 |
2019 |
1
🦁
|
